Aspire Health Science

Name

Aspire Health Science

Legal name

Aspire Health Science, LLC

Website

https://aspire2cure.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Cell Therapy Contract Development & Manufacturing (CDMO)

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (62151)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYHLAGABAD

Cell Therapy CDMO

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

SECONDARYHLAGABAK

Clinical Trial Material (CTM) Manufacturing & Supply CDMO

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

SECONDARYHLAGABAH

Sterile Fill-Finish & Aseptic Manufacturing CDMO

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

SECONDARYEUAKAIAC

Radiopharmaceutical Manufacturing & CDMO (Synthesis, GMP, Packaging, QA/QC)

Energy, Utilities & Environment/Nuclear Energy/Nuclear Materials, Radiation Services & Isotopes (Medical/Industrial)

Keywords

• Cell therapy manufacturing
• CGMP manufacturing services
• Contract development organization
• Cellular therapy CDMO
• Biopharmaceutical manufacturing

Headquarters

HQ city

Orlando

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Infrastructure, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Contract Manufacturing Services: cGMP manufacturing of cellular therapies for clinical trials, providing clinical manufacturing capacity for biotech companies and healthcare institutions. Revenue generated through project-based manufacturing agreements.
2. Development Services: Process development and analytical development services to help transition therapies from bench-side to scalable clinical-grade manufacturing. Includes IND preparation support and regulatory strategy consulting.
3. Research Services: Collaborative research partnerships with industry leaders and human subject research support including Flow cytometry and ELISA services in core facilities.
4. QC Testing Services: Standalone quality control testing services for external clients including bacterial endotoxin testing, sterility testing, and mycoplasma detection with defined turnaround times.
5. Consulting Services: Regulatory and commercialization consulting including IND preparation, clinical manufacturing guidance, and partnership/licensing opportunity evaluation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Aspire Health Science is a clinical-stage contract development and manufacturing organization (CDMO) that provides cGMP manufacturing, process development, research, QC testing, and regulatory consulting services for cell-based therapies including stem cells, immune cells, and regenerative medicine products. Operating from an FDA-registered, ISO Class 7 cleanroom facility in Orlando, Florida, the company serves biotech firms and healthcare institutions developing cellular therapies for clinical trials, and also develops proprietary products such as the ACT-20 MSC therapy for COVID-19 pneumonia.

Product overview

Aspire Health Science operates as a contract development and manufacturing organization (CDMO) offering integrated services for cellular therapies. The company provides five core service lines: Manufacturing Services (cGMP clinical manufacturing with technology transfer and logistics), Development Services (process and analytical development), Research Services (flow cytometry, ELISA, and translational research), QC Testing Services (endotoxin, sterility, mycoplasma testing), and Consulting Services (IND preparation and commercialization support). The company also develops proprietary products including ACT-20 (MSCs-based therapy for COVID-19 pneumonia) and manufactures licensed products such as ACP-01 (Angiogenic Cell Precursors for Critical Limb Ischemia) under agreement with Hemostemix Inc.

Differentiator

Problem solved

Functional benefit

Products and services

• Manufacturing Services cGMP clinical manufacturing of cellular therapies for clinical trials, including technology transfer, cGMP manufacturing, and storage/logistics services. Targeted at biotech companies and healthcare institutions developing cell-based therapies.
• Development Services

Quantifiable outcome

• Manufacturing cellular therapies for clinical trials since 2018 with high success rates
• +1 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Hemostemix Inc.coreStrategic or Co-development Partner · 6 July 2020Licensing agreement with Hemostemix Inc. where Aspire is responsible for manufacturing and managing clinical trial activities including patient data collections and processing of ACP-01 cell therapy for Critical Limb Ischemia indication. The Phase II clinical trial for FDA and Health Canada reached midpoint with 65 subjects treated and 42 patients having completed 6-month follow-ups.
• NeoProgen, Inc.coreStrategic or Co-development Partner · 6 May 2020Aspire announced a strategic collaboration with NeoProgen, Inc., a Baltimore-based preclinical stage therapeutics company specializing in novel cell-based cardiac therapies for heart regeneration. Under the agreement, Aspire is responsible for the cGMP manufacturing of a clinical-grade Master Cell Bank from immortalized clonal isolate derived from human neonatal cardiac stem/progenitor cells (nCPCs) discovered by Dr. Sunjay Kaushal at University of Maryland, Baltimore. Aspire will also manufacture specific cell and cell-free (secretome) based therapies for future clinical trials.
• Kingsman Scientific Management Inc.minorImplementation/ SI/ Consulting PartnerKingsman Scientific Management provides both strategic and high-level project management to support and accelerate development of novel technologies at Aspire Health Science.
• BioFloridaminorOthersAspire Health Science is a member of BioFlorida, the voice of Florida's life sciences industry representing 6,200 establishments and research organizations in biopharmaceuticals, medical technology, healthIT and bioagriculture sectors.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Lonza: Lonza is one of the largest global CDMOs with a dedicated Cell & Gene Technologies business offering cGMP manufacturing, viral vectors, and cell therapy services. Comparable as a cell therapy CDMO peer, though significantly larger in scale and geographic footprint.
• Charles River Laboratories: Charles River Laboratories is a major contract research and CDMO organization offering cell therapy manufacturing, safety assessment, and CDMO services. Overlaps with Aspire in cGMP cell therapy manufacturing for clinical-stage biotech clients.
• Catalent: Catalent is a broad global CDMO with biologics and cell therapy capabilities, providing development, manufacturing, and analytical services to biotech and pharma clients. Aspire competes in the same client-serving CDMO category but at a much smaller scale.

Others

• Vineti: Vineti provides a cell therapy orchestration and chain-of-identity/custody software platform used alongside CDMO manufacturing services. Comparable ecosystem participant that supports cell therapy commercialization workflows similar to those Aspire serves.

Direct peers

• RoslinCT: RoslinCT is a UK-based cell therapy CDMO offering cGMP manufacturing, process development, and analytical services for cell and gene therapies. Directly comparable to Aspire in scale and service offering, focused on clinical-stage cell therapy manufacturing for biotech clients.
• Andelyn Biosciences: Andelyn Biosciences is a US-based cell and gene therapy CDMO offering cGMP manufacturing, process development, and analytical services. Comparable to Aspire as a clinical-stage cell therapy manufacturing partner for biotech clients.
• Genezen: Genezen is a US-based cell and gene therapy CDMO with cGMP viral vector and cell therapy manufacturing capabilities serving clinical-stage biotechs. Comparable to Aspire in its focus on early-phase cell therapy clients needing cGMP capacity and development support.
• Cell and Gene Therapy Catapult: Cell and Gene Therapy Catapult operates large-scale cGMP manufacturing facilities for cell and gene therapies in the UK, supporting clinical and commercial-stage clients. Aspire's CDMO positioning for cell therapy development and manufacturing is directly comparable.
• Hitachi Chemical Advanced Therapeutics Solutions (HCATS): HCATS operates cGMP cell therapy manufacturing facilities focused on autologous and allogeneic cell therapies for clinical and commercial clients. Directly comparable to Aspire in cell therapy CDMO service model and client base.

Emerging players

• FUJIFILM Cellular Dynamics: FUJIFILM Cellular Dynamics is a developer and manufacturer of iPSC-derived cell therapies and related CDMO services. Adjacent to Aspire's cell therapy focus with overlapping expertise in cellular therapy manufacturing under cGMP conditions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Aspire2Cure
• Facebookfacebook.com/Aspire2Cure
• LinkedInlinkedin.com/company/aspire-health-science-llc

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aspire Health Science